Back
Sage Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
SAGE
Sage Therapeutics
Last Price:
$9.15
Seasonality Move:
-9.7%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAGE is experiencing slight selling pressure.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.18 | Sell |
20-day SMA: | 9.18 | Sell |
50-day SMA: | 7.75 | Buy |
200-day SMA: | 7.04 | Buy |
8-day EMA: | 7.59 | Buy |
20-day EMA: | 4.62 | Buy |
50-day EMA: | 2.24 | Buy |
200-day EMA: | 0.62 | Buy |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.5 | Buy |
Relative Strength Index (14 RSI): | 66.64 | Buy |
Chaikin Money Flow: | -811838 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.9 - 9.68) | Buy |
Bollinger Bands (100): | (6.72 - 8.58) | Buy |
Sage Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 9.13 while SAGE 8-day simple moving average is 9.18, which is a Sell signal.
-
The stock price of SAGE is 9.13 while Sage Therapeutics 20-day SMA is 9.18, which makes it a Sell.
-
Sage Therapeutics 50-day simple moving average is 7.75 while SAGE share price is 9.13, making it a Buy technically.
-
SAGE stock price is 9.13 and Sage Therapeutics 200-day simple moving average is 7.04, creating a Buy signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $9.13. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
571.7M
Price in USD:
9.13
Share Volume:
1.6M
Sage Therapeutics 52-Week Range
52-Week High:
13.47
52-Week Low:
4.62
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 9.13 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 9.13 while SAGE 8-day exponential moving average is 7.59, which is a Buy signal.
-
The stock price of SAGE is 9.13 while Sage Therapeutics 20-day EMA is 4.62, which makes it a Buy.
-
Sage Therapeutics 50-day exponential moving average is 2.24 while SAGE share price is 9.13, making it a Buy technically.
-
SAGE stock price is 9.13 and Sage Therapeutics 200-day simple moving average is 0.62, creating a Buy signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is 2.5, suggesting Sage Therapeutics is a Buy
-
Sage Therapeutics Relative Strength Index (RSI) is 66.64, which suggest Sage Therapeutics is overbought
-
The Bollinger Bands (25) for Sage Therapeutics is (7.9 - 9.68), which suggest Sage Therapeutics is a Buy
-
The Bollinger Bands (100) for Sage Therapeutics is (6.72 - 8.58), which suggest Sage Therapeutics is a Buy
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.